Mr. Speaker, I want to thank the hon. gentleman for his tremendous speech. I remember a speech like that a while ago from Mr. Chuck Cadman, when he was here, after the loss of his son. I take to heart the member's speech. I can assure him that nobody on this side of the House would ever accuse him of bias with respect to a bill that would have the potential to save thousands of lives now and in the future.
My question to the member is this. Because these drug companies are all big multinational or international companies and we have trade deals, for example, with NAFTA and others, does he foresee any problems with respect to the bill being challenged on a legal front through areas like Chapter 11 of NAFTA?
Can he also say what other countries, like France, Germany, Britain, Holland, Australia, or the United States, would do in terms of Vanessa's law? Is there anything similar out there that we can mirror as well? It would be interesting to know of his research on what other countries are doing concerning this very important issue.